Anixa Biosciences (NASDAQ:ANIX) Announces Quarterly Earnings Results

Anixa Biosciences (NASDAQ:ANIX) issued its quarterly earnings results on Friday. The company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02, Zacks reports.

Anixa Biosciences Stock Performance

Shares of Anixa Biosciences stock opened at $2.25 on Friday. The business’s fifty day moving average price is $2.92 and its 200 day moving average price is $3.02. The stock has a market capitalization of $72.40 million, a P/E ratio of -5.77 and a beta of 0.90. Anixa Biosciences has a twelve month low of $2.14 and a twelve month high of $5.13.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ANIX shares. D. Boral Capital reiterated a “buy” rating and set a $10.00 target price on shares of Anixa Biosciences in a research report on Tuesday, November 19th. HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Anixa Biosciences in a report on Tuesday, November 19th.

About Anixa Biosciences

Anixa Biosciences, Inc, a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer.